1. Main page
  2. Biotechnology
  3. Orphazyme

Orphazyme

9 Decision Makers · 9 Verified Contacts & Email Format

orphazyme.com
📍 Copenhagen, Hovedstaden, DenmarkBiotechnology🗓 Est. 2009👥 51–100 employees

About Orphazyme

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Email Format

{first_name}@orphazyme.com — 100.0%

sarah@orphazyme.com

Leadership & Decision Makers

Contact details of 9 Orphazyme decision makers

Shilpa Chatlani

Senior Director, Medical Affairs LinkedIn

  • Work email

    s****a@orphazyme.com

Anders Hinsby

Chief Executive Officer

Thomas Kirkegaard Jensen

Chief Scientific Officer

Paul Merrigan

Chief Commercial Officer

Claus Sundgreen

Medical Director

Thomas Blaettler

Chief Medical Officer

Christophe Bourdon

Chief Executive Officer

Tim Kanter

Vice President Market Access, Trade and Pricing

Anders Fink Vadsholt

Chief Financial Officer

General Emails

General company emails, e.g. customer support lines

    usmedinfo@orphazyme.com

    General Inquiries

    contact@orphazyme.com

    General Inquiries

    last_initial@orphazyme.com

    Unclassified inbox

    tlg@orphazyme.com

    Unclassified inbox

Verify Orphazyme Emails

Similar Companies like Orphazyme

Medtronic

medtronic.com
Biotechnology · Minneapolis, MN · Est. 1949 · Above 10001 employees

HQ: Minneapolis, MN

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Alexion Pharmaceuticals

alexion.com
Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Explore similar firms in the Biotechnology sector

Company Info

orphazyme.com

45 70 70 29 80

Copenhagen, Hovedstaden, Denmark

Specialization: Genetics, Therapeutics,
Legal Name: ORPHAZYME A/S
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Founded Date: 2009
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ORPH
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 45 70 70 29 80
Last Investment Activity: Feb 21, 2024
Investments Activity: Feb 21, 2024 Oct 11, 2023 Oct 11, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.